The leading source for credible citizen reporting

Help | Login | Join Allvoices

Mainstream News

This event is older than two months and is no longer active. Some links older than two months could be broken.

Click here to post a new related report

Osiris shares tumble after failed stem cell study

Source: Baltimore Sun

Columbia : SC : USA | 2 months ago

0 0

Osiris Therapeutics Inc., the company bidding to bring the first stem-cell therapy to market, fell the most in three years after its Prochymal drug failed to help bone-marrow transplant patients survive a life-threatening immune reaction called graft-versus-host disease.

Reach
Credibility

More News From: Columbia : SC : USA

Related Allvoices Contributions

living fat

By: bwilson10001

we be rockin

13 days ago
Breakthrough that could help cancer victims grow new breasts

By: TauseefAhmed

A revolutionary operation could soon allow women to regrow their breasts after cancer surgery. The technique offers fresh hope to the thousands of women every year whose breasts are removed in a mastectomy. Current reconstructive techniques produce far from perfect results and can leave scars. The new method would create breasts ...

17 days ago
monkeys are fat

By: bobbybrown

monkeys are fat

about 1 month ago
Your Body-Fat Wants to Kill You

By: dustgeer

Researchers know that your body-fat is not simply a storage place for excess calories, but is in fact an active tissue that secretes multiple compounds. It communicates with other tissues, including the liver, muscles, pancreas and the brain. In a “normal” person, communication between body-fat and other body tissues helps to ...

4 days ago

News Stories

Pravda, Russia: Fat May Provide Stem Cells

News Source: Uinta County News | 2 months ago

U.S researchers disovered that fat sucked out of chunky thighs or flabby bellies might provide an easy source of stem cells. The finding may help to invent a new and promising technology. They found immature fat cells in the material removed...
Osiris shares tumble after failed stem cell study

News Source: Baltimore Sun | 2 months ago

Osiris Therapeutics Inc., the company bidding to bring the first stem-cell therapy to market, fell the most in three years after its Prochymal drug failed to help bone-marrow transplant patients survive a life-threatening immune reaction called graft-...
Fat cells may be relatively easy to change for better.

News Source: Denver Post | 2 months ago

That fat you've been carrying on your hips, thighs and belly can be transformed with relative ease into cells that eventually may be capable of repairing a wide range of your damaged or diseased tissues, according to a new report. Stem cells found in...
Boston Globe: Genzyme Corp.

News Source: Androscoggin News | 2 months ago

A drug that Cambridge-based Genzyme is developing in partnership with Osiris Therapeutics Inc., the adult stem cell treatment Prochymal, failed in two late-stage clinical trials. Osiris said the product did not reach its main goals in studies that...
New Scientist: Adult stem-cell therapy fails crucial tests

News Source: Uinta County News | 2 months ago

It's been a bad few weeks for stem cell clinical trials. First Geron of Menlo Park , California , was forced to put a pioneering trial of human embryonic stem cells on hold because of safety concerns. Now Osiris Therapeutics of Columbia ,...
CNBC: Osiris' Prochymal fails 2 late-stage studies

News Source: Androscoggin News | 2 months ago

Osiris Therapeutics Inc. said Tuesday its stem-cell drug candidate Prochymal failed two late-stage studies focusing on graft vs. host disease, according to preliminary results. Graft vs. host disease is a side effect of a bone marrow transplant in...